Rx Medicare

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older…

Read More…

Related Posts

• Three Clinical Presentations On Tapentadol Extended Release Tablets For Chronic Pain Featured At 2009 American Pain Society Annual Meeting
• Lilly Resubmits Cymbalta(R) Supplemental New Drug Application For Chronic Pain To U.S. Food And Drug Administration
• New Drug Application Submitted For Acurox(r) Tablets – MSNBC
• Fear Of Prescription Drug Abuse Affects Pain Management
• Pain management failing as fears of prescription drug abuse rise
• FDA’s Woodcock Discusses Pain Management And Drug Safety In Nov. 26, 2009 Issue Of The New England Journal Of Medicine
• New Data Published In The Journal Population Health Management Show Significant Misuse Of Pain Medication Among Chronic Pain Population
• Discovery That Active Ingredients In Marijuana Spread And Prolong Pain Has Implications For Medical Use Of Drug And Concepts Of Chronic Pain
• FDA Approves EMBEDA(TM) For Management Of Moderate To Severe Chronic Pain
• NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
• Tapentadol Tablets For Moderate To Scute Pain In Over 18s Now Available For Use In The United States
• Cadence Pharmaceuticals Submits Acetavance New Drug Application For The Treatment Of Acute Pain And Fever
• Program Helps Improve Management Of Chronic Pain
• Pelvic Pain And Surgeries In Women Before Interstitial Cystitis/Painful Bladder Syndrome – Chronic Pelvic Pain, BPS And Pelvic Surgical Procedures
• Behavioral Problems In Childhood Double The Risk Of Chronic Widespread Pain In Adult Life

Tags: application, chronic, drug, extended, management, pain, submitted, tablets, tapentadol

This entry was posted on Wednesday, December 2nd, 2009 at 11:12 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.